Sodium-Glucose Cotransporter 2 Inhibitors in the Era of COVID-19 Pandemic: Is the Benefit to Risk Ratio Still Favorable?

Koufakis, Theocharis; Metallidis, Symeon; Zebekakis, Pantelis; Ajjan, Ramzi A; Kotsa, Kalliopi

Koufakis, Theocharis; Metallidis, Symeon; Zebekakis, Pantelis; Ajjan, Ramzi A; Kotsa, Kalliopi.

Koufakis T; Division of Endocrinology and Metabolism and Diabetes Centre, First Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA University Hospital, Greece.
Metallidis S; Infectious Diseases Division, First Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA University Hospital, Greece.
Zebekakis P; Division of Endocrinology and Metabolism and Diabetes Centre, First Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA University Hospital, Greece.
Ajjan RA; Infectious Diseases Division, First Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA University Hospital, Greece.
Kotsa K; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, UK.

J Diabetes Sci Technol ; 14(4): 745-747, 2020 Jul.

Article in English | MEDLINE | ID: covidwho-505675

Subject(s)

Coronavirus Infections/epidemiology; Diabetes Mellitus, Type 1/drug therapy; Diabetes Mellitus, Type 2/drug therapy; Pneumonia, Viral/epidemiology; Sodium-Glucose Transporter 2 Inhibitors/adverse effects; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use; Betacoronavirus; COVID-19; Cardiovascular Diseases/complications; Cardiovascular Diseases/therapy; Cytokines/metabolism; Diabetes Mellitus, Type 1/complications; Diabetes Mellitus, Type 2/complications; Diabetic Ketoacidosis/complications; Humans; Metformin/administration & dosage; Oxidative Stress; Pandemics; Prognosis; Risk Assessment; Risk Factors; SARS-CoV-2

Keywords

COVID-19; SGLT2 inhibitors; diabetes; diabetic ketoacidosis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Diabetes Mellitus, Type 1 / Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: J Diabetes Sci Technol Journal subject: Endocrinology Year: 2020 Document Type: Article Affiliation country: 1932296820932155

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google